Patent details

LUC00132 Product Name: Risankizumab

Basic Information

Publication number:
LUC00132
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP117819490
Legal Status:
Inactive
Application number:
LUC00132
First applicant's nationality:
Procedural language:
French

Marketing Authorization

Marketing Authorization Number:
EU/1/19/1361
Marketing Authorization Type:
Marketing Authorization Date:
30/04/2019
Marketing Authorization Status:
Accepted
Marketing Authorization Country:
Luxembourg (LU)

Dates

Filing date:
14/10/2019
First Marketing Authorization date:
30/04/2019
Grant date:
16/07/2020
Activation date:
Publication date:
16/10/2019
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
30/04/2034
SPC Extension Expiration:
30/04/2034
Rejection date:
Withdrawal date:

Owner

From:
14/10/2019
 
 

Name:
Boehringer Ingelheim International GmbH
Address:
Binger Strasse 173, 55216 Ingelheim am Rhein, Germany (DE)

Agent

Name:
Dennemeyer & Associates S.A.
From:
14/10/2019
Address:
55, rue des Bruyères, L-1274, HOWALD, Luxembourg (LU)
To:

Publication

Bulletin

1

Bulletin Heading:
SPC1
Bulletin edition number:
2019/12
Publication date:
07/11/2019
Description:
Section C : Published requests for Supplementary Protection Certificates – I1 publication

2

Bulletin Heading:
SPC2
Bulletin edition number:
2020/09
Publication date:
04/08/2020
Description:
Section D : Granted supplementary protection certificates – I2 publication

Annual Fees

Annual Fee Due Date:
01/12/2031
Annual Fee Number:
21
Annual Fee Amount:
410 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
14/10/2019 General Document 1
16/10/2019 Outgoing Correspondence 1
16/07/2020 Certificate 1
14/10/2019 General Document 3
16/07/2020 Outgoing Correspondence 1
14/10/2019 General Document 1
16/07/2020 Publication 1
14/10/2019 General Document 1
14/10/2019 General Document 34
14/10/2019 General Document 4
14/10/2019 Application Form 6
16/10/2019 Publication 1